Synthesis and structure-activity relationships of fibrinolytic bis(tetrahydroisoquinolines). 1971

L J Fliedner, and J M Schor, and M J Myers, and I J Pachter

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
December 1974, Journal of medicinal chemistry,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
January 2015, European journal of medicinal chemistry,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
January 2019, Inorganic chemistry,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
April 1979, Biochemical pharmacology,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
January 2020, Annals of the New York Academy of Sciences,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
December 1974, Journal of medicinal chemistry,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
January 1997, Journal of medicinal chemistry,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
August 2011, Molecules (Basel, Switzerland),
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
June 2014, Chemical reviews,
L J Fliedner, and J M Schor, and M J Myers, and I J Pachter
May 1991, Journal of medicinal chemistry,
Copied contents to your clipboard!